The following is an edited excerpt.
A University of Iowa law professor says the U.S. Supreme Court has given new guidance to medical researchers working with human genes to find cures to diseases, but the court’s ruling may prompt some researchers to be more secretive about their work until they’ve produced a break-through.
Jason Rantanan is a patent law expert who teaches classes about trademarks and intellectual property. “One of the things that has been troubling many of my researcher friends is the difficulty in sequencing the entire human genome because you’ve got these patents on isolated DNA sequences — if you have to get a license for each one of these isolated DNA patents, then that gets very, very complicated and difficult to do,” Rantanan says.
Share this article
Read the full story here: Professor says patent ruling won’t impact agribusiness research of GMOs
